Actively Recruiting
Australian National Program Evaluating Finger-stick Point-of-Care Testing to Improve Hepatitis C Diagnosis and Treatment in At-Risk Populations
Led by Kirby Institute · Updated on 2026-09-28
80000
Participants Needed
16
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether increasing the use of finger-stick point-of-care testing for hepatitis C virus HCV infection can improve diagnosis and treatment rates. The study is observational and focuses on people at risk for HCV infection who access services such as drug treatment clinics, needle and syringe programs, homelessness support, mental health services, prisons, and mobile outreach. The goal is to support national and state strategies aiming to eliminate HCV by 2030 by improving testing and treatment uptake. Participants will be offered point-of-care HCV RNA testing through finger-stick blood samples at various service sites. This testing approach allows for quicker diagnosis by reducing the need for multiple clinic visits. The program includes training for operators, quality assurance, and logistics for scaling up testing across different community health settings. Participants do not receive treatment within the study but those testing positive for HCV RNA will be connected to standard care for further assessment and treatment. During the study, participants will undergo point-of-care testing, and data will be collected on testing acceptance, HCV prevalence, and treatment initiation and completion. Researchers will measure the proportion of infected participants who start treatment within 12 weeks and track treatment outcomes up to 12 months. The study will run until 2029, and participants involvement focuses on testing and monitoring outcomes rather than receiving study treatments directly.
CONDITIONS
Brief Title
The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Research Team
D
David Silk, BSc
S
Simon Comben, BSc, MN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here